NYSE - Nasdaq Real Time Price
USD
Johnson & Johnson (JNJ)
274.48
+3.44
(+1.27%)
As of 2:14:38 PM EDT. Market Open.
Trade JNJ on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreAnalyst Insights
Top Analyst
UBS
59/100
Analyst Price Targets
Analyst Recommendations
-
Strong Buy
-
Buy
-
Hold
-
Underperform
-
Sell
Latest Rating
Date
10/16/2026
Analyst
Wells Fargo
Rating Action
Maintains
Rating
Overweight
Price Action
Raises
Price Target
275 -> 287
Top Analysts
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more| Analyst
|
Overall Score
|
Direction Score
|
Price Score
|
Latest Rating
|
Price Target
|
Date
|
|---|---|---|---|---|---|---|
|
UBS
|
59 | 65 | 87 | Buy
|
320 | 2026-09-03 |
|
RBC Capital
|
57 | 61 | 100 | Outperform
|
280 | 2026-10-15 |
|
Citigroup
|
54 | 56 | 100 | Buy
|
303 | 2026-10-05 |
|
Wells Fargo
|
49 | 49 | 78 | Overweight
|
287 | 2026-10-16 |
|
Raymond James
|
49 | 48 | 100 | Outperform
|
265 | 2026-07-16 |
|
Guggenheim
|
48 | 43 | 79 | Buy
|
287 | 2026-10-08 |
|
Goldman Sachs
|
41 | 36 | 79 | Buy
|
240 | 2025-12-19 |
|
Morgan Stanley
|
37 | 20 | 100 | Overweight
|
292 | 2026-10-15 |
|
Barclays
|
36 | 24 | 92 | Equal-Weight
|
255 | 2026-04-15 |
|
Bernstein
|
34 | 23 | 60 | Market Perform
|
208 | 2026-01-09 |
Rows per page
1-10 of 13
Upgrades & Downgrades
| Maintains | Wells Fargo: Overweight to Overweight | 10/16/2026 |
| Maintains | Morgan Stanley: Overweight to Overweight | 10/15/2026 |
| Maintains | Leerink Partners: Outperform to Outperform | 10/14/2026 |
| Maintains | Wells Fargo: Overweight to Overweight | 10/14/2026 |
| Maintains | RBC Capital: Outperform to Outperform | 10/14/2026 |
| Reiterates | Guggenheim: Buy to Buy | 10/7/2026 |
